Status:
COMPLETED
Muscle Relaxation Therapy With Odorant Cue
Lead Sponsor:
Emory University
Conditions:
Generalized Anxiety Disorder
Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A novel procedure for generalized anxiety disorder where an odorant cue is paired with the state of deep relaxation during training. It is hypothesized that by smelling the odor in an anxiety-provokin...
Detailed Description
We hypothesize that by presenting a novel odor to a patient in a state of deep relaxation, the odor will serve as a conditioned inhibitory stimulus, or safety signal, in anxiety-provoking situations. ...
Eligibility Criteria
Inclusion
- GAD without a comorbid active major psychiatric disorder.
- GAD must be the primary active psychiatric disorder.
- GAD determined via the Mini International Neuropsychiatric Interview (MINI).
Exclusion
- Significant medical illness that might interfere with the relaxation therapy or with training using the odorant.
- Actively abusing alcohol.
- Illicit substances.
- Currently using rapid-acting anxiolytic agents (e.g. benzodiazepines, hydroxyzine).
- Started an antidepressant, antipsychotic or mood stabilizing agent within three months of screening visit.
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00208910
Start Date
November 1 2003
End Date
May 1 2005
Last Update
November 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University School of Medicine
Atlanta, Georgia, United States, 30329